• Campus Access
  • About MPG.eBooks
Skip to content
Search Tips
  • Home>
  • Patient group input submission...
  • Table of Contents
Language
  • Advanced
Cover Image
Read Now

Patient group input submissions: Ivabradine (Lancora) for heart failure, NYHA class II to IV.

Bibliographic Details
Corporate Author: Canadian Agency for Drugs and Technologies in Health
Format: eBook
Language:English
Published: Ottawa (ON) Canadian Agency for Drugs and Technologies in Health 2017, 2017 Jun
Series:CADTH common drug review
Subjects:
Patient Participation
Ivabradine / Therapeutic Use
Canada
Treatment Outcome
Patient Satisfaction
Health Surveys
Heart Failure / Drug Therapy
Online Access:
https://www.ncbi.nlm.nih.gov/books/NBK533856
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
    • Export to EndNoteWeb
    • Export to EndNote
    • Export to MARC
    • Export to BibTeX
  • Description
  • Table of Contents
  • Staff View
Table of Contents:
  • Includes bibliographical references

Similar Items

  • Ivabradine hydrochloride (Lancora)
    Published: (2017)
  • Patient group input submissions: Omalizumab (Xolair) for asthma, severe persistent
    Published: (2017)
  • Pharmacoeconomic review report: Ivabradine hydrochloride (Lancora)
    Published: (2017)
  • Pharmacoeconomic review report: Ivabradine hydrochloride (Lancora)
    Published: (2017)
  • Patient group input submissions: Ixekizumab (Taltz) for the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy
    Published: (2017)
Logo Max Planck Digital Library
  • Advanced Search
  • Recently Uploaded
  • Search History
  • Disclaimer
  • Privacy Policy
  • Cookie Settings
  • Contact
Loading...